Dr. Jung-Mo Ahn, Associate Professor of Chemistry, University of Texas at Dallas
September 14, 2022
In this episode, we discuss the use of small molecules as targeted treatments to interrupt the regulatory pathways responsible for cancer growth, neurodegenerative diseases, and other conditions, with relatively minimal off-target effects.
